Uchida K, Aoki K, Yamaguchi H
Teikyo University Research Center for Medical Mycology.
Jpn J Antibiot. 1991 Sep;44(9):1013-9.
In vitro antifungal activities of a new morpholine agent, amorolfine (MT-861) were investigated, against 39 strains of Malassezia furfur (11 stock cultures and 28 clinical isolates) and 8 strains (stock cultures) of Malassezia pachydermatis, in comparison with those of 2 reference drugs, clotrimazole (CTZ) and bifonazole (BFZ). Of the 3 antifungal agents, MT-861 exhibited strongest antifungal activities against the stock cultures of M. furfur and M. pachydermatis with average MIC values of 0.428 and 0.174 micrograms/ml, respectively; and the average BFZ activity was less than 1/10, and the average CTZ activity was 1/100, of the average MT-861 activity. All of the clinical isolates of M. furfur also showed high susceptibilities, though they were more susceptible to BFZ and CTZ.
研究了新型吗啉类制剂阿莫罗芬(MT - 861)对39株糠秕马拉色菌(11株标准菌株和28株临床分离株)及8株厚皮马拉色菌(标准菌株)的体外抗真菌活性,并与两种对照药物克霉唑(CTZ)和联苯苄唑(BFZ)进行比较。在这3种抗真菌药物中,MT - 861对糠秕马拉色菌和厚皮马拉色菌标准菌株表现出最强的抗真菌活性,平均MIC值分别为0.428和0.174微克/毫升;BFZ的平均活性不到MT - 861平均活性的1/10,CTZ的平均活性为MT - 861平均活性的1/100。所有糠秕马拉色菌临床分离株也显示出高敏感性,不过它们对BFZ和CTZ更敏感。